Blue dye could boost radiation for tough head and neck cancers
NCT ID NCT07435415
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests whether injecting methylene blue (a dye) directly into tumors can make radiation therapy work better for people with head and neck cancer that has come back and is resistant to radiation. Ten participants will receive weekly tumor injections plus daily radiation for six weeks. The main goal is to check safety and see if the combination causes fewer severe side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
China medical university hospital
Taichung, Taiwan, 404, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital peer support: a new weapon against cancer treatment anxiety?
- Can targeted radiation boost Immunotherapy's power against head and neck cancer?
- Could a simple mouthwash protect cancer patients from Radiation's painful side effects?
- Can tailored nutrition boost recovery from head and neck surgery?
- Can less radiation be safer for throat cancer?
- Can a scan tell who needs more surgery after head and neck cancer?